NEOGEN CORP 8K

Neogen Corporation reported Q4 and FY26 results, detailed operational initiatives (including Petrifilm manufacturing transition and a planned genomics divestiture to Zoetis), and issued FY27 financial guidance.

Neogen Corporation filed a Form 8-K to furnish its press release announcing financial results for the fourth quarter and full fiscal year ended May 31, 2026, and to provide guidance for fiscal 2027. The company reported Q4 FY26 revenue of $225.3 million, essentially flat year over year but with 4.3% core revenue growth, driven by 5.8% core growth in Food Safety and a modest 0.5% core increase in Animal Safety as supply constraints eased. For FY26, revenue declined 2.7% to $870.4 million while core growth was 1.9%, and Neogen recorded a Q4 net loss of $11.3 million (EPS of $(0.05)), contrasted with adjusted net income of $18.7 million (adjusted EPS of $0.09) and Q4 adjusted EBITDA of $45.4 million with a 20.2% margin. Operationally, the company highlighted progress on transitioning Petrifilm manufacturing to its Lansing site beginning November 2026, continued efforts to complete the previously announced $160 million sale of its global Genomics business to Zoetis by the end of the first half of FY27 (with expected net proceeds of about $140 million largely earmarked for debt reduction), regulatory developments in Australia and New Zealand review processes for that divestiture, and the launch of a new global go-to-market and solutions-based selling model. Neogen also issued FY27 guidance calling for $880–$885 million of revenue and $180–$182 million of adjusted EBITDA, including an estimated $92 million of revenue and $13 million of adjusted EBITDA from the Genomics division, and provided Q1 FY27 guidance of $207–$209 million of revenue and about $37 million of adjusted EBITDA, noting expected seasonal weakness early in the year with improving revenue and profitability as sales and operational initiatives ramp.

Filing Facts

CIK

711377

Ticker

-

Form

8K

Source Type

sec

Accession

0001193125-26-324860

Alert Tier

7